Park Compounding Pharmacy Recalls Methylcobalamin Vials Due to Sterility Concerns
Park Compounding Pharmacy is recalling specific vials of Methylcobalamin 1000mcg/mL due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility, which poses a risk of serious health consequences such as infection, meeting the criteria for a Severe rating.
Plain-English summary
Chen Shwezin, Inc. dba Park Compounding Pharmacy is recalling two vials of Methylcobalamin 1000mcg/mL, 10mL vials. The recall is being conducted because of a lack of assurance of sterility for all sterile compounded products within their expiry date.
The affected product is identified by Lot # 09102015@6 and has an expiration date of 3/8/16. The recall is limited to California. The FDA has classified this recall as Class II.
Consumers who have this specific product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- METHYLCOBALAMIN 1000MCG/ML, 10mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805) 497-8258
- Manufacturer
- Chen Shwezin, Inc. dba Park Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 09102015@6
- Exp 3/8/16
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Chen Shwezin, Inc. dba Park Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Chen Shwezin, Inc. dba Park Compounding Pharmacy
See all →- SeverePark Compounding Pharmacy Recalls TRI-MIX Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls Prostaglandin PGE-1 Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls TRI-MIX Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls Caffeine and Sodium Benzoate Vials
FDA (Drugs) · 2015-11-04
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereMedPark Pharmacy Recalls Methylcobalamin Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2017-06-14
- SevereGuardian Pharmacy Recalls Methylcobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereUS Compounding Recalls Methylcobalamin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SeverePark Compounding Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereFDA Recalls Methylcobalamin Vials Due to Lack of Sterility Assurance
FDA (Drugs) · 2016-10-05
- SevereMethylcobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24